珍菊降压片联合丹参片治疗老年原发性高血压患者56例

摘要

目的：观察珍菊降压片联合丹参片治疗老年原发性高血压的临床疗效。方法：将112例老年原发性高血压患者随机分为观察组、对照组各56例。对照组口服珍菊降压片，1～2粒/次，3次/d；观察组在对照组的基础上加用丹参片，3粒/次，3次/d。2组均连续治疗6个月。比较治疗前后2组患者血压及心率、心肌耗氧指数、左心室肥厚逆转及不良反应发生情况。结果：总有效率观察组为96.43%，对照组为83.93%，观察组优于对照组（P＜0.05）。2组患者血压均较治疗前降低(P＜0.05)，观察组降低更明显(P＜0.05)。心率及心肌耗氧指数2组治疗后均明显改善(P<0.05)，观察组改善更明显(P＜0.05)。舒张期左心室内径(LVID)、室间隔厚度(IVST)、左心室后壁厚度(LVPWT)、左心室肌重量(LVW)、左心室体积指数(LVWI)2组治疗后均明显改善(P＜0.05)，观察组改善更明显(P＜0.05)。结论：珍菊降压片联合丹参片治疗老年原发性高血压临床疗效显著，可有效控制血压，降低心肌耗氧量，改善左心室功能。%Objective: To investigate the efficacy of Zhenju hypertensive tablet combined with Danshen tablet in the treatment of elderly patients with essential hypertension and cardiac protective effect. Methods: 96 cases of el-derly patients with essential hypertension from January 2013 to June 2014 were selected as research subjects. They were randomly divided into two groups, 48 cases in each group. The control group was treated with Zhenju hyperten-sive tablet, 1-2 tablets / time, 3 times a day; observation group Zhenju hypertensive tablet joint Salvia tablets 3 /times, three times a day treatment, they were observed for 6 months. Blood pressure measurement was texted twice weekly in patients. before and after treatment blood pressure and heart rate, myocardial oxygen consumption index, reversal of left ventricular hypertrophy were compared in two groups of patients, adverse events were recorded. Re-sults :After treatment, blood pressure in both groups of patients reduced compared with before treatment(P<0.05), the total efficiency of the observation group was significantly higher (P<0.05) than control group, two groups of patients with changes in blood pressure, myocardial oxygen consumption index of the degree of improvement left ventricular reverse the situation in the observation group was significantly higher (P<0.05). Conclusion :Zhenju hypertensive tablets combined with Danshen tablet in the treatment of elderly patients with essential hypertension, which can effec-tively control blood pressure, have a protective effect on the heart, more effective than single-use Zhenju hypertensive tablets.